Position in TAK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$748,472
-$57,573 QoQ
Shares Held
46,692
+7.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#114
of 375 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Probity Advisors, Inc. holds $1,472,967 across 3 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (50.8% of the industry book) .
All Filings in TAK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $748,472 | 46,692 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $806,045 | 43,523 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $677,120 | 43,433 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $628,583 | 42,936 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $638,930 | 41,328 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $579,201 | 38,951 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $573,225 | 43,295 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $615,669 | 43,296 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $512,876 | 39,635 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $344,180 | 24,779 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $310,772 | 21,778 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $270,539 | 17,488 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $229,915 | 14,635 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $195,748 | 12,548 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $156,846 | 12,093 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||